/SYBE

SYBE Stock - SYBLEU Inc

Q: What is the analyst price target for SYBE?

Analyst price target information is not currently available for SYBE.

Q: What is SYBE's market cap?

Market capitalization information is not currently available for SYBE.

Healthcare|Biotechnology|OTC

$0.06+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.06

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SYBE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.29

52W High$0.06

52W Low$0.04

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019
Revenue	$11,696	$11,700	$4,052	N/A
Gross Profit	$11,696	$11,700	$4,052	N/A
Gross Margin	100.0%	100.0%	100.0%	N/A
Operating Income	$-149,180	$-56,373	$-88,252	$-46,308
Net Income	$-180,304	$-245,347	$-101,846	$-46,308
Net Margin	-1541.6%	-2097.0%	-2513.5%	N/A
EPS	$-0.02	$-0.02	$-0.01	$-0.01

Company Overview

SYBLEU INC. intends to engage primarily in the development of regenerative medical applications. The company was founded in 2020 and is based in Bronx, New York.